XML 55 R44.htm IDEA: XBRL DOCUMENT v3.10.0.1
Re-engineering and Impairment Costs (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2018
Jul. 01, 2017
Jun. 30, 2018
Jul. 01, 2017
Dec. 30, 2017
Restructuring Reserve [Roll Forward]          
Beginning of the year balance     $ 45.4 $ 1.6 $ 1.6
Re-engineering and impairment charges $ 2.1 $ 32.6 9.7 $ 34.9 [1] 63.7
Non-cash charges     (0.4)   (0.4)
Restructuring Reserve, Foreign Currency Translation Gain (Loss)     0.6   0.0
End of period balance 30.8   30.8   45.4
South America          
Restructuring Reserve [Roll Forward]          
Re-engineering and impairment charges 0.0   0.4    
North America          
Restructuring Reserve [Roll Forward]          
Re-engineering and impairment charges 1.3   2.0    
Asia Pacific          
Restructuring Reserve [Roll Forward]          
Re-engineering and impairment charges 0.0   0.8    
Europe          
Restructuring Reserve [Roll Forward]          
Re-engineering and impairment charges $ 0.8   6.5    
Revitalization Plan July 2017 [Member]          
Restructuring Cost and Reserve [Line Items]          
Write-down of inventories     $ 0.7    
Cash Payments as a Percentage of Re-engineering Costs, Expected 90.00%   90.00%    
Severance          
Restructuring Reserve [Roll Forward]          
Cash expenditures     $ (14.7)   (12.7)
Severance | Revitalization Plan July 2017 [Member]          
Restructuring Cost and Reserve [Line Items]          
Severance as a Percentage of Re-engineering Costs, Expected 65.00%   65.00%    
Other          
Restructuring Reserve [Roll Forward]          
Cash expenditures     $ (8.6)   $ (6.8)
Minimum [Member] | Revitalization Plan July 2017 [Member]          
Restructuring Cost and Reserve [Line Items]          
Restructuring and Related Cost, Expected Cost $ 90.0   90.0    
Maximum [Member] | Revitalization Plan July 2017 [Member]          
Restructuring Cost and Reserve [Line Items]          
Restructuring and Related Cost, Expected Cost $ 100.0   $ 100.0    
[1] (a)See Note 7 to the Consolidated Financial Statements for a discussion of re-engineering and impairment charges.